Hypertension Perspective

• Apr 11 2025 This Week in Cardiology  
  theheart.org on Medscape, April 11, 2025
• Rare Cor Triatriatum Case in Patient With HIV Uncovered A 34-year-old woman with HIV presents with dyspnoea, revealing a rare congenital heart defect.
  Medscape UK, April 11, 2025
• ACC 2025 Little Learned From Trials That Are Positive by Design Dapagliflozin after TAVI? Semaglutide for claudication? Two trials designed to be positive should not warrant new indications for these drugs writes John Mandrola, MD.
  theheart.org on Medscape, April 10, 2025
• Know SSRI Side Effects Dr. Paauw warns about common side effects of selective serotonin reuptake inhibitors that may be seen in primary care.
  Medscape Internal Medicine, April 10, 2025
• ACC 2025 Fluid Restriction in HF: Let’s Not Torture Patients   Drs Piña and Hsich discuss the FRESH-UP trial that challenged the dogma of fluid restriction in heart failure and provide practical strategies for optimizing medical therapy instead.
  theheart.org on Medscape, April 09, 2025
• S2 Episode 3: Can We Prevent Myelofibrosis? The New Interferon Era   Join Drs Tania Jain and Brandi Reeves as they discuss primary myelofibrosis and post-ET (essential thrombocythemia) and post-PV (polycythemia vera) myelofibrosis.
  Medscape, April 08, 2025
• Apr 04 2025 This Week in Cardiology   Trials from the 2025 American College of Cardiology scientific sessions, including the WARRIOR, PROTECT TAVI, DAPATAVI, and SOUL are reviewed by John Mandrola, MD
  theheart.org on Medscape, April 04, 2025
• ACC 2025 Keep Fighting INOCA After Neutral WARRIOR Trial   Drs O’Donoghue, Handberg, and Bairey-Merz discuss the WARRIOR trial of intensive medical therapy in women with nonobstructive symptomatic CAD, presented at the ACC 2025 Scientific Session.
  theheart.org on Medscape, April 04, 2025
• Mar 28 2025 This Week in Cardiology   Stopping oral anticoagulation after AF ablation, the core problem with paradoxes like the smoker’s paradox, chronic total occlusion PCI, and an ACC/EHRA preview are discussed by John Mandrola, MD, in this week’s podcast.
  theheart.org on Medscape, March 28, 2025
• Coaching Boosts GLP-1 Effectiveness in Managing Weight Loss Regaining weight after discontinuing GLP-1s is common, but ongoing coaching can help support patients to maintain their weight loss.
  Medscape Diabetes & Endocrinology, March 27, 2025
• When Should You Consider Weight-Loss Meds for Obesity?   Dr Sarah Barenbaum discusses when to consider antiobesity medications.
  Medscape, March 27, 2025
• US Falls Behind Other Countries in Avoidable Deaths   It just doesn’t work to keep throwing money at poor health outcomes.
  Medscape, March 25, 2025
• Complement 3 Glomerulopathy: 5 Differentials to Know C3G, a rare kidney disease often associated with devastating progression, requires careful evaluation to distinguish it from other glomerulopathies. Here are five must-know differentials.
  Medscape Nephrology, March 24, 2025
• Immunosuppressive Therapies in C3 Glomerulopathy Medscape spoke with Andrew Bomback, MD, MPH, about the use of steroids, pegcetacoplan, and iptacopan in C3G.
  Medscape Nephrology, March 24, 2025
• Episode 2: New Guidelines and the Lupus Nephritis Kidney Conundrum   Join Drs Maureen McMahon and Brad Rovin as they discuss the KDIGO, ACR and EULAR guidelines as they relate to lupus nephritis.
  Medscape, March 20, 2025
• GLP-1s Are Crazy Effective — Just Not Cost-Effective   We know they are expensive, but isn’t the cost recouped by the healthcare savings? Dr F. Perry Wilson explains.
  Medscape, March 17, 2025
• Mar 14 2025 This Week in Cardiology   Listener feedback, resistant hypertension, K-binders for MRA use in heart failure, nutritional epidemiology, and a positive study for vitamin D are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, March 14, 2025
• Should We Be Concerned About These BP Medicines? Assess risk factors and advise patients before prescribing thiazides and ACE inhibitors for blood pressure management.
  Medscape Internal Medicine, February 28, 2025
• S3 Episode 1: MASLD and Type 2 Diabetes: Screening and Management   Drs Carol H. Wysham and Scott Isaacs discuss incorporating the screening and management of metabolic dysfunction-associated steatotic liver disease in endocrine practice.
  Medscape, February 25, 2025
• A Woman With Post-Coital Bleeding This vulvar tumour case highlights the need for multidisciplinary care to manage coexisting malignancies and infections.
  Medscape UK, February 21, 2025